AQR Capital Management’s ARS Pharmaceuticals SPRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
2025
Q2
$282K Buy
2025
Q1
$140K Buy
2022
Q3
Sell
2022
Q2
$84K Buy
2022
Q1
$38K Buy